In 2019, several ranitidine products were recalled worldwide after the detection of N-Nitrosodimethylamine (NDMA), a probable human carcinogen. NDMA is an environmental contaminant commonly found in water and foods but is harmful at higher levels. The discovery of NDMA in ranitidine raised significant public health concerns, leading to widespread recalls and regulatory scrutiny.
